…

Morgan Stanley just upgraded Johnson & Johnson to Overweight, raising the price target to $262 on the back of an...

28/01/2026

1 views

JPM Healthcare Conference 2026: Pharma Outlook

The JPM Healthcare Conference kicks off next week, and pharma leaders are ready to reveal their 2026 strategies. From massive...

09/01/2026

7 views

Rigel Pharmaceuticals shares leaped almost 50% in just three months, with the CEO boasting substantial business growth and profitability. What’s...

30/10/2025

4 views

Ionis Pharmaceuticals’ stock is skyrocketing, fueled by a promising drug pipeline. What’s driving this biotech’s rise, and is it time...

08/10/2025

2 views